<DOC>
	<DOCNO>NCT00800605</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy investigational Vero cell-derived , trivalent , seasonal influenza vaccine prevent infection influenza virus antigenically similar one three strain vaccine . Subjects randomize double-blind fashion receive single intramuscular injection either investigational vaccine placebo . Blood drawn subject determination hemagglutination inhibition antibody titer Days 0 21 , body temperature injection site reaction monitor daily 7 day . In addition , subject must return clinic promptly swab sample nose throat take whenever feel flu symptom subject monitor adverse event Day 180 .</brief_summary>
	<brief_title>Immunogenicity Study Inactivated Influenza Vaccine ( Split Virus , Vero Cell Derived ) Prevent Culture Confirmed Influenza Infection</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject understanding study Subject agree study provision Subject give write informed consent prior study entry Subject accessible telephone electronic mail receive reminder study site If female capable bearing child , subject negative urine pregnancy test result within 24 hour vaccination Study Day 0 agrees employ adequate birth control measure first 60 postvaccination day . Subject risk factor complication influenza infection define Centers Disease Control Prevention ( CDC , 2008a ) : Pregnancy Chronic disorder pulmonary cardiovascular system include asthma ( hypertension consider high risk condition ) Chronic renal disorder Chronic hepatic disorder Chronic hematological disorder Chronic metabolic disorder ( include diabetes mellitus thyroid disorder ) Immunosuppression ( include immunosuppression cause medication , congenital etiology HIV ) Any condition compromise respiratory function handle respiratory secretion increase risk aspiration ( e.g. , cognitive dysfunction , spinal cord injury , seizure disorder neuromuscular disorder ) Residence nursing home chronic care facility house person age chronic medical condition Household contact child age 0 59 month someone include risk category list Employment health care worker Subject unable lead independent life result either physical mental handicap Subject history severe allergic reaction anaphylaxis ( e.g. , urticaria asthma clinically severe ) Subject oral temperature &gt; = 99.5° F ( 37.5°C ) day vaccination study . [ NOTE : A subject meeting exclusion criterion may reschedule vaccination study entry later date provide certain requirement [ study protocol ] meet ) Subject rash dermatologic condition tattoo may interfere injection site reaction rating Subject receive blood transfusion , blood product immunoglobulins within 90 day study entry Subject receive live vaccine within 4 week inactivate subunit vaccine within 2 week study entry Subject previously vaccinate influenza 2008/2009 northern hemisphere influenza season Subject functional surgical asplenia Subject know suspect problem alcohol drug abuse ; Subject administer investigational drug within six week prior study entry concurrently participate clinical study include administration investigational product Subject member team conduct study dependent relationship study investigator . Dependent relationship include close relative ( i.e. , child , spouse/partner , sibling , parent ) well employee investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>